Recent Company News

• 07:31 PM ET Oct 21, 2025
  

  Starpharma Holdings confirms receipt of previously announced upfront payment of $5.5M (~A$8.5M) from Genentech (A$0.29, -0.02)

• 08:55 PM ET Oct 20, 2025
  

  Insider transaction: Starpharma Holdings chairman Rob Thomas discloses purchase of 450K shares - Appendix 3Y (A$0.28, -0.01)

• 09:47 PM ET Sep 29, 2025
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 12:56 AM ET Oct 03, 2025
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (74 total)

• 12:59 AM ET Oct 02, 2025
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (75 total)

• 12:58 AM ET Oct 01, 2025
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (59 total)

• 12:58 AM ET Sep 30, 2025
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (65 total)

• 07:51 PM ET Sep 29, 2025
  

  Starpharma Holdings enters into research and option agreement with Radiopharm Theranostics to develop a novel radiotherapy asset (A$0.22, 0.00)